The Nrf2 pathway promotes the proliferation of ovarian cancer cells and the generation of chemoresistance by inhibiting oxidative stress induced by chemotherapeutic drugs, ultimately promoting the progression and metastasis of ovarian cancer [69]. The gene discussed is NFE2L2; the disease is ovarian carcinoma.